606
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: a pharmacovigilance-pharmacodynamic/pharmacokinetic assessment through an analysis of the vigibase®

, , , , , , , , & show all
Pages 1099-1108 | Received 07 Jun 2019, Accepted 12 Sep 2019, Published online: 26 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ping Zou, Mingxing Guo & Jingbo Hu. (2022) Evogliptin for the treatment option for type 2 diabetes: an update of the literature. Expert Review of Clinical Pharmacology 15:6, pages 747-757.
Read now
André J. Scheen. (2021) Careful use to minimize adverse events of oral antidiabetic medications in the elderly. Expert Opinion on Pharmacotherapy 22:16, pages 2149-2165.
Read now
Faizan Mazhar, Vera Battini, Michele Gringeri, Marco Pozzi, Giulia Mosini, Albaraa Mohammed N. Marran, Shahzad Akram, Robbert P. van Manen, Sonia Radice, Emilio Clementi & Carla Carnovale. (2021) The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database. Expert Opinion on Biological Therapy 21:9, pages 1281-1290.
Read now
Kazuki Orime & Yasuo Terauchi. (2020) Efficacy and safety of saxagliptin for the treatment of type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 21:17, pages 2101-2114.
Read now

Articles from other publishers (19)

Vera Battini, Sara Rocca, Greta Guarnieri, Anna Bombelli, Michele Gringeri, Giulia Mosini, Marco Pozzi, Maria Nobile, Sonia Radice, Emilio Clementi, Antonio Schindler, Carla Carnovale & Nicole Pizzorni. (2023) On the potential of drug repurposing in dysphagia treatment: New insights from a real-world pharmacovigilance study and a systematic review. Frontiers in Pharmacology 14.
Crossref
Michele Fusaroli, Valentina Giunchi, Vera Battini, Michele Gringeri, Roberto Rimondini, Marco Menchetti, Sonia Radice, Marco Pozzi, Maria Nobile, Emilio Clementi, Fabrizio De Ponti, Carla Carnovale, Emanuel Raschi & Elisabetta Poluzzi. (2022) Exploring the underlying mechanisms of drug‐induced impulse control disorders: a pharmacovigilance‐pharmacodynamic study. Psychiatry and Clinical Neurosciences 77:3, pages 160-167.
Crossref
Vera Battini, Robbert P. Van Manen, Michele Gringeri, Giulia Mosini, Greta Guarnieri, Anna Bombelli, Marco Pozzi, Maria Nobile, Sonia Radice, Emilio Clementi & Carla Carnovale. (2023) The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase. Frontiers in Pharmacology 14.
Crossref
S.H. Ma, C.Y. Wu, Y.S. Lyu, Y.J. Chou, Y.T. Chang & C.Y. Wu. (2022) Association between sodium‐glucose co‐transporter 2 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: a nationwide population‐based cohort study. Journal of the European Academy of Dermatology and Venereology 36:8, pages 1318-1324.
Crossref
Carla Carnovale, Vera Battini, Michele Gringeri, Marina Volonté, Maria Chiara Uboldi, Andrea Chiarenza & Giovanni Passalacqua. (2022) Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review. World Allergy Organization Journal 15:7, pages 100658.
Crossref
Vera Battini, Alessandra Mari, Michele Gringeri, Francesca Casini, Francesco Bergamaschi, Giulia Mosini, Greta Guarnieri, Marco Pozzi, Maria Nobile, Gianvincenzo Zuccotti, Emilio Clementi, Sonia Radice, Valentina Fabiano & Carla Carnovale. (2022) Antibiotic-Induced Neutropenia in Pediatric Patients: New Insights From Pharmacoepidemiological Analyses and a Systematic Review. Frontiers in Pharmacology 13.
Crossref
Shereen Mowaka, Nermeen Ashoush, Mariam M. Tadros & Bassam M. Ayoub. (2021) Investigation of Pharmacokinetic Parameters of Trelagliptin in Egyptian Volunteers Using Sensitive LC-MS/MS: A Comparative Study with a Japanese Population. Journal of Analytical Methods in Chemistry 2021, pages 1-9.
Crossref
Patrick M. Jedlowski, Mahdieh F. Jedlowski & Maryam T. Fazel. (2021) DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020. American Journal of Clinical Dermatology 22:6, pages 891-900.
Crossref
Francesco BELLINATO, Martina MAURELLI, Donatella SCHENA, Paolo GISONDI & Giampiero GIROLOMONI. (2021) Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid. Italian Journal of Dermatology and Venereology 156:4.
Crossref
Ayan Roy, Jayaprakash Sahoo, Niya Narayanan, Chandhana Merugu, Sadishkumar Kamalanathan & Dukhabandhu Naik. (2021) Dipeptidyl peptidase-4 inhibitor-induced autoimmune diseases: Current evidence. World Journal of Diabetes 12:9, pages 1426-1441.
Crossref
Carla Carnovale, Michele Gringeri, Vera Battini, Giulia Mosini, Elena Invernizzi, Faizan Mazhar, Francesco Bergamaschi, Mara Fumagalli, Gianvincenzo Zuccotti, Emilio Clementi, Sonia Radice & Valentina Fabiano. (2021) Beta‐blocker‐associated hypoglycaemia: New insights from a real‐world pharmacovigilance study. British Journal of Clinical Pharmacology 87:8, pages 3320-3331.
Crossref
Faizan Mazhar, Vera Battini, Marco Pozzi, Elena Invernizzi, Giulia Mosini, Michele Gringeri, Annalisa Capuano, Cristina Scavone, Sonia Radice, Emilio Clementi & Carla Carnovale. (2021) Hyponatremia Following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports From the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review. International Journal of Neuropsychopharmacology 24:6, pages 477-489.
Crossref
Payal M. Patel, Virginia A. Jones, Khalaf Kridin & Kyle T. Amber. (2020) The role of Dipeptidyl Peptidase‐4 in cutaneous disease. Experimental Dermatology 30:3, pages 304-318.
Crossref
Faizan Mazhar, Vera Battini & Carla Carnovale. (2021) Antiemetic Drugs During Pregnancy: What Can We Learn From Spontaneous Reporting System Database Analyses?. JAMA Pediatrics 175:3, pages 326.
Crossref
Jing Huang, Yuntao Jia, Shusen Sun & Long Meng. (2020) Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system. BMC Pharmacology and Toxicology 21:1.
Crossref
Francesco Moro, Luca Fania, Jo Linda Maria Sinagra, Adele Salemme & Giovanni Di Zenzo. (2020) Bullous Pemphigoid: Trigger and Predisposing Factors. Biomolecules 10:10, pages 1432.
Crossref
Hemin Lee, Hye Jin Chung, Ajinkya Pawar, Elisabetta Patorno & Dae Hyun Kim. (2020) Evaluation of Risk of Bullous Pemphigoid With Initiation of Dipeptidyl Peptidase–4 Inhibitor vs Second-generation Sulfonylurea. JAMA Dermatology 156:10, pages 1107.
Crossref
Milo Gatti, Emanuel Raschi & Fabrizio De Ponti. (2020) Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis. European Journal of Clinical Pharmacology.
Crossref
Giovanni Antonio Silverii, Ilaria Dicembrini, Besmir Nreu, Chiara Montereggi, Edoardo Mannucci & Matteo Monami. (2020) Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials. Endocrine 69:3, pages 504-507.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.